We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

ELISA – News and Features

News

Antibody Labeling Guide - Go Direct

Innova Biosciences has launched a new antibody labeling guide to provide greater awareness of how easy it is for scientists to label primary antibodies within their own laboratories.
News

New Diagnostics Company from Berlin

Astra Biotech GmbH, Berlin, Germany is a new company whose core focus is the development of innovative diagnostics for the identification of an individual’s predisposition to disease.
News

Detecting Cancer with the Prick of a Finger

BYU researchers create microdevice to speed up cancer detection.
News

Innovators Program Offers Free Antibodies for Sharing Data

Thermo Fisher Scientific, have announced the Thermo Scientific Pierce Innovators Program.
News

Biotrak™ Assay Methods for use with Biochrom Microplate Readers

Biochrom Ltd announces increased functionality in its microplate readers that now enable users of GE Healthcare’s popular Biotrak range of immunoassay kits to download pre-programmed method definitions.
News

BioGenes Has Developed Cellmid’s Midkine Blood Test and Reports Manufacture of First Kits

BioGenes GmbH, a supplier of GMP compliant immunoassay and antibody services, has developed and optimized the first ever fully validated ELISA protocol for Midkine detection in blood serum.
News

New Diagnostics Company from Berlin

Astra Biotech GmbH, Berlin, Germany is a new company whose core focus is the development of innovative diagnostics for the identification of an individual’s predisposition to disease.
News

AbD Serotec Secures Exclusive Worldwide License to Research Antibody from The Institute of Cancer Research

Deal strengthens AbD Serotec’s position as a source of core reagents to study cell proliferation and cell kinetics.
News

Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study

Intercell AG today announced results from a Phase II clinical trial involving the company's investigational nosocomial vaccine candidate (IC43) against infections with the bacterium Pseudomonas aeruginosa, a leading cause of hospital-acquired infections with increasing antibiotic resistance and hence a very high unmet medical need.
News

Thermo Fisher Scientific Introduces Guide to Good Washing Practice

The online guide is designed to provide detailed guidance on obtaining secure and reliable performance with every use of the Thermo Scientific Wellwash microplate washers.
Advertisement